Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most lethal cancers, according to a report in "Nature." Pancreatic cancer is among the deadliest,

"It's really exciting, because when we talk about curing cancer, it's not really a single monolithic disease," he added. "There are probably hundreds of different targets for ever